Hennion & Walsh Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.82M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.49M | Sell |
|
|||||
|
2023
Q2 | $3.25M | Sell |
|
|||||
|
2023
Q1 | $3.53M | Sell |
|
|||||
|
2022
Q4 | $4.5M | Buy |
|
|||||
|
2022
Q3 | $1.28M | Sell |
|
|||||
|
2022
Q2 | $920K | Buy |
|
|||||
|
2022
Q1 | $1.22M | Buy |
|
|||||
|
2021
Q4 | $1.37M | Buy |
|
|||||
|
2021
Q3 | $575K | Buy |
|
|||||
|
2021
Q2 | $460K | Buy |
|